Published in Hum Mutat on March 01, 2003
p53 isoforms can regulate p53 transcriptional activity. Genes Dev (2005) 6.76
Loss of function of def selectively up-regulates Delta113p53 expression to arrest expansion growth of digestive organs in zebrafish. Genes Dev (2005) 2.44
The isoforms of the p53 protein. Cold Spring Harb Perspect Biol (2010) 1.76
Viral hepatocarcinogenesis. Oncogene (2010) 1.73
Medulloblastomas overexpress the p53-inactivating oncogene WIP1/PPM1D. J Neurooncol (2007) 1.50
Mutant p53 mediates survival of breast cancer cells. Br J Cancer (2009) 1.33
Single-nucleotide polymorphisms in the p53 signaling pathway. Cold Spring Harb Perspect Biol (2009) 1.30
Uncovering the role of p53 splice variants in human malignancy: a clinical perspective. Onco Targets Ther (2013) 1.27
A p53-derived apoptotic peptide derepresses p73 to cause tumor regression in vivo. J Clin Invest (2007) 1.27
p53-targeted LSD1 functions in repression of chromatin structure and transcription in vivo. Mol Cell Biol (2008) 1.15
Overexpressed TP73 induces apoptosis in medulloblastoma. BMC Cancer (2007) 1.05
Increased efficacy of doxorubicin delivered in multifunctional microparticles for mesothelioma therapy. Int J Cancer (2010) 1.02
p53-Dependent and p53-independent induction of insulin-like growth factor binding protein-3 by deoxyribonucleic acid damage and hypoxia. J Clin Endocrinol Metab (2005) 1.01
U-box-type ubiquitin E4 ligase, UFD2a attenuates cisplatin mediated degradation of DeltaNp63alpha. Cell Cycle (2008) 1.00
Pharmacological activation of the p53 pathway by nutlin-3 exerts anti-tumoral effects in medulloblastomas. Neuro Oncol (2012) 0.97
Primary adenocarcinomas of lower esophagus, esophagogastric junction and gastric cardia: in special reference to China. World J Gastroenterol (2003) 0.95
The molecular biology of vestibular schwannomas and its association with hearing loss: a review. Genet Res Int (2012) 0.90
p73 G4C14-to-A4T14 polymorphism and risk of second primary malignancy after index squamous cell carcinoma of head and neck. Int J Cancer (2009) 0.89
Novel endogenous angiogenesis inhibitors and their therapeutic potential. Acta Pharmacol Sin (2015) 0.87
p73 G4C14 to A4T14 polymorphism is associated with colorectal cancer risk and survival. World J Gastroenterol (2010) 0.87
Analysis of gene expression profiles in HeLa cells in response to overexpression or siRNA-mediated depletion of NASP. Reprod Biol Endocrinol (2009) 0.87
DeltaNp63 protein expression in uterine cervical and endometrial cancers. J Cancer Res Clin Oncol (2006) 0.86
Cataloging and organizing p73 interactions in cell cycle arrest and apoptosis. Nucleic Acids Res (2008) 0.86
Evaluation of 1p36 markers and clinical outcome in a skull base chordoma study. Neuro Oncol (2007) 0.86
Regulation of ΔNp63α by NFκΒ. Cell Cycle (2010) 0.85
Expression of NF-κB p65 phosphorylated at serine-536 in rectal cancer with or without preoperative radiotherapy. Radiol Oncol (2011) 0.85
Depletion of the histone chaperone tNASP inhibits proliferation and induces apoptosis in prostate cancer PC-3 cells. Reprod Biol Endocrinol (2011) 0.84
Genetic variants of the p53 and p73 genes jointly increase risk of second primary malignancies in patients after index squamous cell carcinoma of the head and neck. Cancer (2011) 0.84
CARP-1 functional mimetics: a novel class of small molecule inhibitors of medulloblastoma cell growth. PLoS One (2013) 0.83
TAp73 induction by nitric oxide: regulation by checkpoint kinase 1 (CHK1) and protection against apoptosis. J Biol Chem (2011) 0.83
Protein phosphatase 1 inhibits p53 signaling by dephosphorylating and stabilizing Mdmx. Cell Signal (2012) 0.82
Protein kinase C-dependent phosphorylation regulates the cell cycle-inhibitory function of the p73 carboxy terminus transactivation domain. Mol Cell Biol (2009) 0.82
Association of p53 codon 72 polymorphism with risk of second primary malignancy in patients with squamous cell carcinoma of the head and neck. Cancer (2010) 0.81
WIP1 enhances tumor formation in a sonic hedgehog-dependent model of medulloblastoma. Neurosurgery (2012) 0.81
Association of a p73 exon 2 GC/AT polymorphism with colorectal cancer risk and survival in Tunisian patients. Virchows Arch (2010) 0.80
Roles of small RNAs in the effects of nutrition on apoptosis and spermatogenesis in the adult testis. Sci Rep (2015) 0.79
Involvement of p53 in insulin-like growth factor binding protein-3 regulation in the breast cancer cell response to DNA damage. Oncotarget (2015) 0.79
P53 genetic polymorphism of gastric cancer in Korea. Korean J Intern Med (2006) 0.78
p73alpha is a candidate effector in the p53 independent apoptosis pathway of cisplatin damaged primary murine colonocytes. J Clin Pathol (2004) 0.78
The p53R172H mutant does not enhance hepatocellular carcinoma development and progression. PLoS One (2015) 0.77
Association of p73 G4C14-to-A4T14 polymorphism with non-small cell lung cancer risk. Oncol Lett (2015) 0.77
Microenvironment-Dependent Phenotypic Changes in a SCID Mouse Model for Malignant Mesothelioma. Front Oncol (2013) 0.76
The dominant-negative interplay between p53, p63 and p73: A family affair. Oncotarget (2016) 0.75
p53, p63 and p73 expression and angiogenesis in keratocystic odontogenic tumors. J Clin Exp Dent (2016) 0.75
Nuclear localization of the caspase-3-cleaved form of p73 in anoikis. Oncotarget (2016) 0.75
Identification of two p53 isoforms from Litopenaeus vannamei and their interaction with NF-κB to induce distinct immune response. Sci Rep (2017) 0.75
Relationship of p73 gene polymorphism and additional gene-smoking and gene-obesity interaction with non-small cell lung cancer risk. Oncotarget (2017) 0.75
Milk disrupts p53 and DNMT1, the guardians of the genome: implications for acne vulgaris and prostate cancer. Nutr Metab (Lond) (2017) 0.75
Netrin-1 acts as a survival factor for aggressive neuroblastoma. J Exp Med (2009) 1.36
P73 functionally replaces p53 in Adriamycin-treated, p53-deficient breast cancer cells. Int J Cancer (2005) 1.23
CDK Inhibitors Roscovitine and CR8 Trigger Mcl-1 Down-Regulation and Apoptotic Cell Death in Neuroblastoma Cells. Genes Cancer (2010) 1.16
[Micro-RNA and oncogenesis]. Bull Cancer (2005) 0.90
Analysis of fibroblast growth factor receptor 3 G697C mutation in oral squamous cell carcinomas. Int J Cancer (2007) 0.86
ETV6 gene rearrangements in invasive breast carcinoma. Genes Chromosomes Cancer (2005) 0.85
P53 family: at the crossroads in cancer therapy. Curr Med Chem (2009) 0.81
Involvement of N-terminally truncated variants of p73, deltaTAp73, in head and neck squamous cell cancer: a comparison with p53 mutations. Cell Cycle (2008) 0.79
Retinoic acid receptor alpha amplifications and retinoic acid sensitivity in breast cancers. Clin Breast Cancer (2013) 0.76